Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
The Motley FoolThe prospects of the latter two companies looked better following the European pharmaceutical’s new clinical trial readout.
The prospects of the latter two companies looked better following the European pharmaceutical’s new clinical trial readout.